Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Quest Diagnostics: Q1 Earnings Snapshot

Quest Diagnostics: Q1 Earnings Snapshot

DGX : 136.70 (+5.08%)
Quest Diagnostics: Q4 Earnings Snapshot

Quest Diagnostics: Q4 Earnings Snapshot

DGX : 136.70 (+5.08%)
Firing on All Cylinders Indeed

Investors are seeing some big reactions to earnings results in tech and have a few reasons to think some beaten-up names might be finding their footing.

SBUX : 87.87 (-0.35%)
AAPL : 166.90 (+0.64%)
ROKU : 61.74 (+5.41%)
MTCH : 31.69 (-0.84%)
DASH : 129.36 (+1.64%)
F : 12.94 (+0.47%)
GM : 45.10 (+4.37%)
DGX : 136.70 (+5.08%)
STLA : 24.96 (+1.55%)
KLG : 23.80 (+8.13%)
Quest Diagnostics: Q3 Earnings Snapshot

Quest Diagnostics: Q3 Earnings Snapshot

DGX : 136.70 (+5.08%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1300 (-11.98%)
TELO.VN : 0.170 (-17.07%)
GH : 17.34 (-1.42%)
NTRA : 91.04 (+2.74%)
DGX : 136.70 (+5.08%)
NEO : 14.16 (+5.51%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

/PRNewswire/ -- Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight...

TELO.VN : 0.170 (-17.07%)
TDSGF : 0.1300 (-11.98%)
GH : 17.34 (-1.42%)
NTRA : 91.04 (+2.74%)
DGX : 136.70 (+5.08%)
NEO : 14.16 (+5.51%)
Neway Forms Lab Services Agreement with Quest Diagnostics to Speed Quality ESRD Testing

/PRNewswire/ -- Neway, LLC, the U.S. leader in value-based dialysis lab care, today announced a strategic lab services arrangement with Quest Diagnostics...

DGX : 136.70 (+5.08%)
Quest Diagnostics to Release Third Quarter 2023 Financial Results on October 24, 2023

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report...

DGX : 136.70 (+5.08%)
Quest Diagnostics to Speak at the Baird 2023 Global Healthcare Conference

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Sam Samad,...

DGX : 136.70 (+5.08%)
Quest Diagnostics Releases 2022 Corporate Responsibility Report

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the leader in diagnostic information services, today released its 2022 Corporate Responsibility Report. The...

DGX : 136.70 (+5.08%)

Barchart Exclusives

Should You Buy This Beaten-Down AI Stock for Its 4% Dividend Yield?
Sales of AI-enabled gadgets are expected to drive hardware sales over the next few years. PC maker HP looks like an AI play worth buying for its nearly 4% dividend yield and tepid valuations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar